3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS

It is described a compounds of formula (I): a pharmaceutical composition comprising same, for use in the treatment of cancers, of diseases or conditions characterized by an excess or a deregulated activity of platelets. Also provided is the synthesis of intermediate Il est décrit des composés de for...

Full description

Saved in:
Bibliographic Details
Main Authors PARSONS, RACHEL JANE, MURRAY, JAMES BROOKE, DUNKEL, PETRA, RUDASOVA, MONIKA, MARAGNO, ANA LETICIA, NYERGES, MIKLOS, TIMARI, MATYAS PAL, NOVAK, TIBOR, HERNER, ANDRAS, MADARASZ, ZOLTAN, DODSWORTH, MARK PHILIP, SZIGETI, MARIANNA, WEBB, PAUL, COLLAND, FREDERIC, BEDFORD, SIMON, PACZAL, ATTILA, STROFEK, AGNES, CHANRION, MAIA, DAVIDSON, JAMES EDWARD PAUL, MOLNAR, MARK, STARCK, JEROME-BENOIT, DESOS, PATRICE, KOTSCHY, ANDRAS
Format Patent
LanguageEnglish
French
Published 04.02.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:It is described a compounds of formula (I): a pharmaceutical composition comprising same, for use in the treatment of cancers, of diseases or conditions characterized by an excess or a deregulated activity of platelets. Also provided is the synthesis of intermediate Il est décrit des composés de formule (I) : une composition pharmaceutique connexe à utiliser dans le traitement de cancers, de maladies ou de problèmes caractérisés par un excédent, ou une activité sans régulation, de plaquettes. Il est également décrit la synthèse d'intermédiaires.
Bibliography:Application Number: CA20203148502